Alaunos Therapeutics, Inc. (TCRT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.29M |
| Enterprise Value | 4.91M |
| P/E Ratio | -1.58 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 3,000.31 |
| Price/Book Ratio | 11.47 |
| Enterprise/Revenue | 2,958.98 |
| Enterprise/EBITDA | -2.23 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1,336.67 |
| Operating Margin | -1,352.67 |
AD
Management Effectiveness
| Return On Assets | -2.65 |
| Return On Equity | -2.33 |
Income Statement
| Revenue | 5,000 |
| Revenue/Share | 0 |
| Gross Profit | -1.36M |
| EBITDA | -4.17M |
| Net Income | -4.18M |
| Diluted EPS | -2.2 |
Balance Sheet
| Total Cash | 124,000 |
| Total Cash/Share | 0.05 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.77 |
| Book Value Per Share | 0.27 |
Price History
| 52-Week Change | 20.12 |
| 52-Week High | 4.5 |
| 52-Week Low | 0.72 |
| Moving Average 50 Days | 1.6 |
| Moving Average 200 Days | 2.36 |
Statistics
| Average Volume | 7.44M |
| Shares Outstanding | 2.93M |
| % Held by Institutions | 3.72 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 18, 2024 |
AD
